InvestorsHub Logo
Followers 34
Posts 3008
Boards Moderated 0
Alias Born 02/27/2016

Re: nidan7500 post# 167807

Friday, 10/05/2018 12:07:25 PM

Friday, October 05, 2018 12:07:25 PM

Post# of 463570
Last time was also a late breaking oral. Going after Biogen is interesting. “Confirms Role of Patient Biomarkers” is curious. How will they show it? They CANT just say. “See. The higher concentration patients were the ones that fit our profile and they were the ones that improved”

So, it has to be something new that CONFIRMS.

Longitudinal 148-Week Extension Study for ANAVEX®2-73 Phase 2a Alzheimer’s Disease Demonstrates Maintained Activities of Daily Living Score (ADCS-ADL) and Reduced Cognitive Decline (MMSE) for Patient Cohort on Higher Drug Concentration and Confirms Role of Patient Selection Biomarkers

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News